Drug
Leo43204
Leo43204: highest development phase Phase 3, developed by LEO Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- LEO Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| LEO43204 gel NCT02549352 | Phase 3 | Actinic Keratosis |
Latest
No recent events.
Follow Leo43204 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.